Clinical Trials Logo

Unconsciousness clinical trials

View clinical trials related to Unconsciousness.

Filter by:

NCT ID: NCT00796848 Withdrawn - Diabetes Mellitus Clinical Trials

Reversal of Hypoglycemia Unawareness Using Continuous Glucose Monitoring

Start date: March 2009
Phase: N/A
Study type: Interventional

The purpose of doing this study is to see if continuous glucose monitoring can help people with type 1 diabetes who are sometimes unable to feel if they have a low blood glucose reading. For this study we will be using the Navigator Continuous Glucose Monitor. We think that your body may not have enough of a certain hormone that usually helps people know when they are going low. If you can keep from going low, we think there will be enough of that hormone to help you recognize the symptoms of a low before it happens.

NCT ID: NCT00793741 Completed - Type 1 Diabetes Clinical Trials

Measurement of Glucose Metabolism in Humans Using Magnetic Resonance at 4 Tesla. Substudy: Hypoglycemia Unawareness

Start date: December 2007
Phase: N/A
Study type: Observational

The purpose of this study is to determine whether islet transplantation alters brain glucose concentrations in patients with type 1 diabetes, recurrent hypoglycemia, and hypoglycemia unawareness when compared to that measured prior to transplant in the same subjects.

NCT ID: NCT00160056 Completed - Diabetes Clinical Trials

The Effect of Antecedent Hypoglycaemia on β2-adrenergic Sensitivity

Start date: April 2005
Phase: N/A
Study type: Interventional

Hypoglycaemia unawareness is a common complication in patients with type 1 diabetes and with insulin-treated type 2 diabetes of long duration. The loss of autonomic symptoms to hypoglycemia does not solely depend on loss of adrenaline responses.Differences in sensitivity to catecholamines may also be involved. Reconciling the data on β2-adrenergic receptor polymorphism to those on loss of β-adrenergic sensitivity in diabetic patients with hypoglycemia unawareness, we hypothesize that hypoglycemia unawareness is at least partly the result of desensitization of the β2-adrenergic receptor and that patients who are homozygous for arginine at codon 16 are particularly susceptible for this desensitization process, whereas patients who are homozygous for glycine at codon 16 are resistant for desensitization. Objectives 1. To determine whether, and if so to what extent, antecedent hypoglycemia reduces β2-adrenergic sensitivity in healthy subjects with Arg16 homozygosity. 2. To investigate whether or not healthy subjects with Gly16 homozygosity are resistant to desensitization 3. To confirm that antecedent hypoglycemia reduces the heart rate response to isoproterenol and to assess to what extent this reduced response is mediated by impairments in baroreflex sensitivity.

NCT ID: NCT00143754 Terminated - Hydration Clinical Trials

Effect of Chronic Oral Hydration in Patients With Recurrent Unexplained Syncope

Start date: n/a
Phase: Phase 3
Study type: Interventional

Beneficial effect of chronic hydration with salt supplementation in patients with recurrent unexplained syncope is not established. We sought to determine if chronic oral rehydration with salt supplementation improved the tolerance and hemodynamic responses of patients with unexplained recurrent syncope.